Approval · Notice of Compliance 14249 · 2013
XERESE: Notice of Compliance 14249
Issued March 26, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14249
- Date
- March 26, 2013
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antiviral and corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XERESE | 02404044 | Marketed |
Medicinal ingredients
- ACYCLOVIR 5 PER
- HYDROCORTISONE 1 PER